Your browser doesn't support javascript.
loading
The efficacy and safety of IBI314 on delta and omicron variant of SARS-CoV-2: First-in-human evidence.
Sang, Ling; Cheng, Bo; Yu, Yuheng; Xi, Yin; Wang, Yun; Fan, Bingdong; Li, Jijie; Dai, Jingtao; Gan, Guifen; Tong, Shijun; Sun, Bin; Qi, Xiaojing; Liang, Wenhua; He, Jianxing; Zhong, Nanshan.
Afiliação
  • Sang L; Department of Intensive Care Unit, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China; Guangzhou Laboratory, Guang
  • Cheng B; Department of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou 510120, China; Guangzhou Laborat
  • Yu Y; Department of Intensive Care Unit, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China; Guangzhou Laboratory, Guang
  • Xi Y; Department of Intensive Care Unit, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China; Guangzhou Laboratory, Guang
  • Wang Y; Department of Emergency Intensive Care Unit (EICU), Qinghai Provincial Fourth People's Hospital, China.
  • Fan B; Department of Emergency Intensive Care Unit (EICU), Qinghai Provincial Fourth People's Hospital, China.
  • Li J; Department of Respiratory Medicine, Qinghai Provincial Fourth People's Hospital, China.
  • Dai J; Department of Respiratory Intensive Care Medicine, The Qinghai Provincial Fourth People's Hospital, China.
  • Gan G; Department of Critical Care Medicine, The Affiliated Hospital of Qinghai University, China.
  • Tong S; Department of Critical Care Medicine, The Affiliated Hospital of Qinghai University, China.
  • Sun B; Department of Critical Care Medicine, Qinghai Provincial People's Hospital, China.
  • Qi X; Department of Respiratory and Critical Care Medicine, Qinghai Provincial People's Hospital, China.
  • Liang W; Department of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou 510120, China; Guangzhou Laborat
  • He J; Department of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou 510120, China; Guangzhou Laborat
  • Zhong N; Guangzhou Laboratory, Guangzhou International Biotech Island, Guangzhou 510320, China; Department of Respiratory Medicine, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guang
J Infect ; 85(3): 334-363, 2022 09.
Article em En | MEDLINE | ID: mdl-35691517
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2022 Tipo de documento: Article